| Part B: Supplementary Information Sheet (SIS) |
|
FR Recognition List Number
|
062
|
Date of Entry 05/29/2024
|
|
FR Recognition Number
|
10-135
|
| Standard | |
ISO 11979-7 Fifth edition 2024-01
Ophthalmic implants - Intraocular lenses - Part 7: Clinical investigations of intraocular lenses for the correction of aphakia |
|
Scope/Abstract| This document specifies the particular requirements for the clinical investigations of intraocular lenses that are implanted in the eye in order to correct aphakia. |
|
Extent of Recognition
| Partial recognition. The following part(s) of the standard is (are) not recognized: |
Clause 6.2.2 Additional requirements for toric IOLs
Clause 6.3.3 Additional characteristics to be studied for toric IOL
Clause 6.4 Duration of the investigations - Paragraphs 4 and 5
Clause 6.10.3 Additional inclusion criteria for toric IOL
Annex B - Additional elements for the clinical investigation of toric IOLs |
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
This standard is recognized in part because:
The clauses and annex listed above are in conflict with another recognized standard, see clause 10 and Annex B of ANSI Z80.30 listed below. |
|
Public Law, CFR Citation(s) and Procode(s)*
| Regulation Number |
Device Name |
Device Class |
Product Code |
| §886.3600 |
Intraocular Lens
|
Class 3
|
HQL
|
| §886.3600 |
Lens, Multifocal Intraocular
|
Class 3
|
MFK
|
| §886.3600 |
Lens, Intraocular, Accommodative
|
Class 3
|
NAA
|
| §886.3600 |
Extended Depth Of Focus Intraocular Lens
|
Class 3
|
POE
|
|
Relevant FDA Guidance and/or Supportive Publications*
ANSI Z80.30-2018 (R2023) American National Standard for Ophthalmics - Toric Intraocular Lenses.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
| FDA Technical Contacts
|
| Standards Development Organization
|
| FDA Specialty Task Group (STG)
|
| *These are provided as examples and others may be applicable. |
